Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 15 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2001Characterization of thoracic duct cells that transfer polyarthritisSpargo, L.; Cleland, L.; Wing, S.; Hawkes, J.; Mayrhofer, G.
2014Relationship between plasma omega-3 fatty acids and clinical outcomes in recent onset rheumatoid arthritisProudman, S.; Cleland, L.; Lee, A.; Wechalekar, M.; Metcalf, R.; Sullivan, T.; Spargo, L.; James, M.; Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania)
2012Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low doseProudman, S.; Spargo, L.; Hall, C.; McWilliams, L.; Lee, A.; Rischmueller, M.; Gibson, R.; James, M.; Cleland, L.; Australian Rheumatology Association Annual Scientific Meeting (2012 : Canberra, A.C.T.)
2014A pilot study to assess the impact of patient, genetic and disease factors on response to the disease modifying anti-rheumatic drug leflunomideWiese, M.; Hopkins, A.; Spargo, L.; McWilliams, L.; O'Doherty, C.; Cleland, L.; Proudman, S.; Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania)
2011Decline in hand bone mineral density indicates increased risk for erosive change in early rheumatoid arthritis (RA)Black, R.; Spargo, L.; Schultz, C.; Chatterton, B.; James, M.; Cleland, L.; Hill, C.; Proudman, S.; Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 52nd Annual Scientific Meeting (14 May 2011 - 17 May 2011 : Brisbane, Qld.)
2012Decline in hand bone mineral density indicates increased risk for erosive change in early rheumatoid arthritis (RA)Black, R.; Spargo, L.; Shultz, C.; Chatteron, B.; James, M.; Cleland, L.; Lester, S.; Hill, C.; Proudman, S.; RACP Future Directions in Health Congress 2012 (6 May 2012 - 9 May 2012 : Brisbane, Qld.)
2015Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritisProudman, S.; Cleland, L.; Metcalf, R.; Sullivan, T.; Spargo, L.; James, M.
2016Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term?Wabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Hall, C.; Spargo, L.; Metcalf, R.; Proudman, S.; Wiese, M.
2017Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritisWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; Mcwilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.
2015Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three yearsWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.